The following is a summary of “A nationwide study of two decades of invasive pneumococcal disease in the Faroe Islands, ...

Pneumococcal pneumonia vaccine is under development for the treatment of pneumonia. It is a conjugate vaccine. It is administered through intramuscular as a liquid formulation. It is a new chemical ...

Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and commercialize next-generation PCVs for both ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

The pneumococcal polysaccharide vaccine (PPV) is currently recommended for older adults and high-risk subjects, including patients with chronic obstructive pulmonary disease (COPD) and asthma.

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

Arizona currently has no confirmed human cases of bird flu, although two Pinal County workers were exposed through infected ...

In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...

Healthcare professionals in the U.S. have noticed a significant increase in vaccine hesitancy among their patients, according ...

At Dartmouth Hitchcock Medical Center, 97 patients with pneumonia went to the emergency room between September and November, ...